FreeGulliver LLC’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52.4K Hold
10,000
0.02% 122
2026
Q1
$17.6K Hold
10,000
0.01% 115
2025
Q4
$23.5K Sell
10,000
-100
-1% -$273 0.01% 104
2025
Q3
$30.9K Hold
10,100
0.01% 99
2025
Q2
$28.2K Sell
10,100
-85,400
-89% -$281K 0.01% 85
2025
Q1
$343K Buy
95,500
+5,500
+6% +$22.1K 0.17% 59
2024
Q4
$284K Buy
90,000
+5,000
+6% +$17.9K 0.14% 65
2024
Q3
$240K Sell
85,000
-95,000
-53% -$217K 0.14% 70
2024
Q2
$221K Hold
180,000
0.15% 70
2024
Q1
$143K Buy
180,000
+130,000
+260% +$118K 0.13% 63
2023
Q4
$47.6K Buy
+50,000
New +$49.1K 0.06% 43

Other funds holding CLOV

FreeGulliver LLC's CLOV Position: Q2 2026 in Review

FreeGulliver LLC held its Clover Health Investments (CLOV) position steady in Q2 2026 at 10,000 shares worth $52.4K. The position accounts for 0.02% of the portfolio, ranked #122.

FreeGulliver LLC first reported a position in CLOV in Q4 2023 and has held it in 11 quarters since. The position peaked at $343K in Q1 2025. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • FreeGulliver LLC held 10,000 shares of Clover Health Investments worth $52.4K as of Q2 2026.
  • FreeGulliver LLC left its Clover Health Investments share count unchanged in Q2 2026.
  • Clover Health Investments made up 0.02% of FreeGulliver LLC's portfolio in Q2 2026, its #122 holding.
  • FreeGulliver LLC first reported a position in Clover Health Investments in Q4 2023 and has held it in 11 quarters since.
  • FreeGulliver LLC's Clover Health Investments position peaked at $343K in Q1 2025.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on FreeGulliver LLC's 13F filing for Q2 2026, filed 11 Aug 2026.